Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 3
2004 2
2006 1
2007 2
2008 8
2009 3
2010 5
2011 2
2012 3
2013 2
2014 1
2015 2
2016 3
2017 2
2018 2
2019 5
2020 5
2021 6
2022 1
2023 3
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

66 results

Results by year

Filters applied: . Clear all
Page 1
Bivalent EGFR-Targeting DARPin-MMAE Conjugates.
Karsten L, Janson N, Le Joncour V, Alam S, Müller B, Tanjore Ramanathan J, Laakkonen P, Sewald N, Müller KM. Karsten L, et al. Among authors: laakkonen p. Int J Mol Sci. 2022 Feb 23;23(5):2468. doi: 10.3390/ijms23052468. Int J Mol Sci. 2022. PMID: 35269611 Free PMC article.
Efficacy and Safety of Glycosphingolipid SSEA-4 Targeting CAR-T Cells in an Ovarian Carcinoma Model.
Monzo HJ, Kalander K, Hyytiäinen MM, Elbasani E, Wall J, Moyano-Galceran L, Tanjore Ramanathan J, Jukonen J, Laakkonen P, Ristimäki A, Carlson JW, Lehti K, Salehi S, Puolakkainen P, Haglund C, Seppänen H, Leppä S, Ojala PM. Monzo HJ, et al. Among authors: laakkonen p. Mol Cancer Ther. 2023 Nov 1;22(11):1319-1331. doi: 10.1158/1535-7163.MCT-23-0008. Mol Cancer Ther. 2023. PMID: 37486980
Anagrelide for Gastrointestinal Stromal Tumor.
Pulkka OP, Gebreyohannes YK, Wozniak A, Mpindi JP, Tynninen O, Icay K, Cervera A, Keskitalo S, Murumägi A, Kulesskiy E, Laaksonen M, Wennerberg K, Varjosalo M, Laakkonen P, Lehtonen R, Hautaniemi S, Kallioniemi O, Schöffski P, Sihto H, Joensuu H. Pulkka OP, et al. Among authors: laakkonen p. Clin Cancer Res. 2019 Mar 1;25(5):1676-1687. doi: 10.1158/1078-0432.CCR-18-0815. Epub 2018 Dec 7. Clin Cancer Res. 2019. PMID: 30530703
Homing peptides as targeted delivery vehicles.
Laakkonen P, Vuorinen K. Laakkonen P, et al. Integr Biol (Camb). 2010 Aug;2(7-8):326-37. doi: 10.1039/c0ib00013b. Epub 2010 Jul 26. Integr Biol (Camb). 2010. PMID: 20657951 Review.
Antiangiogenic properties of prostate-specific antigen (PSA).
Mattsson JM, Laakkonen P, Stenman UH, Koistinen H. Mattsson JM, et al. Among authors: laakkonen p. Scand J Clin Lab Invest. 2009;69(4):447-51. doi: 10.1080/00365510903056031. Scand J Clin Lab Invest. 2009. PMID: 19551556 Review.
Hepsin regulates TGFβ signaling via fibronectin proteolysis.
Belitškin D, Pant SM, Munne P, Suleymanova I, Belitškina K, Hongisto HA, Englund J, Raatikainen T, Klezovitch O, Vasioukhin V, Li S, Wu Q, Monni O, Kuure S, Laakkonen P, Pouwels J, Tervonen TA, Klefström J. Belitškin D, et al. Among authors: laakkonen p. EMBO Rep. 2021 Nov 4;22(11):e52532. doi: 10.15252/embr.202152532. Epub 2021 Sep 13. EMBO Rep. 2021. PMID: 34515392 Free PMC article.
Peptide targeting of tumor lymph vessels.
Laakkonen P, Zhang L, Ruoslahti E. Laakkonen P, et al. Ann N Y Acad Sci. 2008;1131:37-43. doi: 10.1196/annals.1413.003. Ann N Y Acad Sci. 2008. PMID: 18519957 Review.
66 results